SCHEMBL10581383

SCHEMBL10581383

O=c1ccc2cccnc2n1N1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.37
▸ CYP2C19 P33261 2/20 0.35
▸ TSHR P16473 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ GMNN O75496 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MMP8 P22894 1/20 0.34
▸ CCR1 P32246 1/20 0.34
▸ THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31124582 0.78 GRM5 (0.37) PARP1CYP2C19TSHRLMNATP53
SCHEMBL7416957 0.73 CA12 (0.48) CYP2C19TSHRMAPTKDM4ECYP3A4
SCHEMBL2614748 0.70 BRD4 (0.50) PARP1CYP2C19TSHRLMNATP53
SCHEMBL29712289 0.70 BRD4 (0.50) PARP1CYP2C19TSHRLMNATP53
SCHEMBL27254155 0.70 PARP1 (0.42) PARP1CYP2C19TSHRLMNATP53
SCHEMBL9577060 0.70 PARP1 (0.46) PARP1CYP2C19TSHRLMNATP53
SCHEMBL29311510 0.70 PARP1 (0.42) PARP1CYP2C19TSHRLMNATP53
SCHEMBL3515138 0.70 DAO (0.47) PARP1CYP2C19TSHRLMNATP53
SCHEMBL25723262 0.70 CYP2C19 (0.42) PARP1CYP2C19TSHRLMNATP53
SCHEMBL30825920 0.69 DRD2 (0.37) CYP2C19TSHRLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302303-A2 Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation SCHERING CORPORATION (US) 1989-02-08 — — EP disclosed
Send feedback